• [1]

    Herst P M，Rowe M R，Carson G M, et al. Functional mitochondria in health and disease. Front Endocrinol, 2017, 8(DOI: 10.3389/fendo.2017.00296)

  • [2]

    Dorn G W，Kitsis Ｒ N．The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble．Circ Ｒes，2015，116（1）: 167-182

  • [3]

    Spang A, Saw J H, Jorgensen S L, et al. Complex archaea that bridge the gap between prokaryotes and eukaryotes. Nature, 2015, 521（7551）:173-179

  • [4]

    Zaremba-Niedzwiedzka K, Caceres E F, Saw J H, et al. Asgard archaea illuminate the origin of eukaryotic cellular complexity. Nature, 2017, 541（7637）:353-358

  • [5]

    Selkoe D J. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev, 2001, 81（2）: 741-766

  • [6]

    Cardoso S M, Pereira C F, Moreira P T, et al. Mitochondrial control of autophagic lysosomal pathway in Alzheimer’ s disease. Exp Neurol, 2010, 223（2）: 294-298

  • [7]

    Tillement L, Lecanu L, Papadopoulos V. Alzheimer’ s disease: effects of β-amyloid on mitochondria. Mitochondrion, 2011, 11（1）: 13-21

  • [8]

    Reddy P H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer’ s disease. Brain Res, 2011, 1415（9）: 136-148

  • [9]

    Benek O, Aitken L, Hroch L, et al. Direct interaction between mitochondrial proteins and amyloid-beta peptide and its significance for the progression and treatment of Alzheimer`s disease. Curr Med Chem, 2015, 22（9）: 1056-1085

  • [10]

    Xie H, Guan J, Borrelli L A, et al. Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. J Neurosci, 2013, 33（43）: 17042-17051

  • [11]

    Hung C H, Ho Y S, Chang R C. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease. Ageing Res Rev, 2010, 9（4）: 447-456

  • [12]

    Du H, Yan S S. Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin D and amyloid beta. Biochim Biophys Acta, 2010, 1802（1）: 198-204

  • [13]

    Veldman B, Wijn A, Knoers N, et al. Genetic and environmental risk factors in Parkinson’ s disease. Clin Neurol Neurosurg, 1998, 100（1）: 15-26

  • [14]

    Enns G M. The contribution of mitochondria to common disorders. Mol Genet Metab, 2003, 80 （1）: 11-26

  • [15]

    Cordato D J, Chan D K. Genetics and Parkinson’ s disease. J Clin Neurosci, 2004, 11（2）: 119-123

  • [16]

    Indran I R, Tufo G, Pervaiz S, et al. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta, 2011, 1807（6）: 735-745

  • [17]

    Dorn G W，Kitsis R N．The mitochondrial dynamism -mitophagy -cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble．Circ Res，2015，116（1）: 167-182

  • [18]

    Boovarahan S R, Kurian G A. Mitochondrial dysfunction: a key player in the pathogenesis of cardiovascular diseases linked to air pollution. Rev Environ Health, 2018, 33（2）：111-122

  • [19]

    Razonova M A, Ryzhkova A I, Sinyov V V. Mitochondrial genome mutations associated with myocardial infarction. Dis Markers, 2018, DOI:10.1155/2018/9749457

  • [20]

    Rustom A, Saffrich R, Markovic I, et al. Nanotubular highways for intercellular organelle transport. Science. 2004, 303（5660）:1007-1010

  • [21]

    Spees J L, Olson S D, Whitney M J, et al. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA, 2006, 103（5）:1283-1288

  • [22]

    Ahmad T, Mukherjee S, Pattnaik B, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J, 2014, 33（9）: 994-1010

  • [23]

    Islam M N, Das S R, Emin M T, et al. Mitochondrial transfer from bone marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med, 2012, 18 （5）:759-765

  • [24]

    Hayakawa K, Esposito E, Wang X, et al. Transfer of mitochondria from astrocytes to neurons after stroke. Nature, 2016, 535（7613）:551-555

  • [25]

    Davis C H, Kim K Y, Bushong E A, et al. Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci USA, 2014, 111（26）: 9633-9638

  • [26]

    Osswald M, Jung E, Sahm F, et al. Brain tumour cells interconnect to a functional and resistant network. Nature, 2015, 528（7580）: 93-98

  • [27]

    Li C J, Chen P K, Sun L Y, et al., Enhancement of mitochondrial transfer by antioxidants in human mesenchymal stem cells. Oxid Med Cell Longev,2017, DOI: 10.1155/2017/8510805

  • [28]

    Wang J C, Liu X, Qiu Y, et al., Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol,2018. 11(1): 11-21

  • [29]

    Rogers R S, Bhattacharya J. When cells become organelle donors. Physiology, 2013, 28 (6):414-422

  • [30]

    Moschoi R, Imbert V, Nebout M, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood, 2016, 128 (2):253-264

  • [31]

    Plotnikov E Y, Khryapenkova T G, Galkina S I, et al. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture. Exp Cell Res, 2010, 316 (15): 2447-2455

  • [32]

    Jackson M V, Morrison T J, Doherty D F, et al., Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the In vitro and In vivo models of ARDS. Stem Cells,2016, 34(8): 2210-2223

  • [33]

    Plotnikov E Y, Khyrapenkova T G, Vasileva A K, et al. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J Cell Mol Med, 2008, 12(5A): 1622-1631

  • [34]

    Acquistapace A, Bru T, Lesault P F, et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells, 2011, 29 (5): 812–824

  • [35]

    Vallabhaneni K, Haller H, Dumler I. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Develop, 2012, 21 (17): 3104-3113

  • [36]

    Yasuda K, Park H C, Ratliff B, et al. Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair. Am J Pathol, 2010, 176 (4): 1685-1695

  • [37]

    Wang Y, Cui J, Sun X,et al. Tunneling nanotube development in astrocytes depends on p53 activation. Cell Death Differ, 2011, 18 (4): 732-742

  • [38]

    Bisharyan Y, Clark T G. Calcium-dependent mitochondrial extrusion in ciliated protozoa. Mitochondrion, 2011, 11(6): 909-918

  • [39]

    Rodriguez A M, Nakhle J, Griessinger E, et al. Intercellular mitochondria trafficking highlighting the dual role of mesenchymal stem cells as both sensors and rescuers of tissue injury. Cell Cycle, 2018. 17(6): 712-721

  • [40]

    Tkach M, Thry C. Communication by extracellular vesicles: where we are and where we need to go. Cell, 2016, 164 (6): 1226-1232

  • [41]

    Alvarez-Dolado M, Pardal R, Garcia-Verdugo J M, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 2003, 425(6961): 968-973

  • [42]

    Osswald M, Jung E, Sahm F, et al. Brain tumour cells interconnect to a functional and resistant network. Nature, 2015, 528(7580): 93-98